Quality of care in gout: a clinical audit on treating to the target with urate lowering therapy in real-world gout patients

Carly A. Janssen* (Corresponding Author), Tim L.Th A. Jansen, Martijn A.H. Oude Voshaar, Harald E. Vonkeman, Mart A.F.J. van de Laar

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

14 Citations (Scopus)
90 Downloads (Pure)


The current paper aimed to describe the quality of care for gout patients by showing the clinical outcomes achieved in two patient cohorts in which differing targeted urate lowering therapy (ULT) treatment approaches were employed, both aiming to reach the European League Against Rheumatism recommended serum urate (sUA) targets. A retrospective medical chart review study was conducted. Data from the medical records of gout patients from two clinical centers in The Netherlands, both applying targeted ULT treatments (albeit using different approaches), were reviewed. Patients in cohort A were given a combination of xanthine oxidase inhibitors with uricosurics if treatment with allopurinol monotherapy failed to reach sUA target levels, whereas patients in cohort B were treated with sequential monotherapy. Data on patient characteristics and clinical outcomes were collected. A total of 177 patient dossiers were included: 99 from cohort A and 78 from cohort B. The great majority (n = 146, 82.5%) of the patients in both cohorts had a current sUA level <360 µmol/L. In addition, more than half (n = 104, 58.8%) of the patients met the stringent sUA target level of <300 µmol/L. The largest reductions in mean sUA levels were observed for patients who were treated with combination therapy. This clinical audit of two cohorts of gout patients provides initial—yet promising—results regarding the proportion of real-world gout patients in whom recommended that sUA target levels can be achieved, and demonstrates the added value that a targeted treatment approach may have in reaching these goals.

Original languageEnglish
Pages (from-to)1435-1440
Number of pages6
JournalRheumatology international
Issue number9
Publication statusPublished - 1 Sept 2017


  • UT-Hybrid-D
  • Gout
  • Hyperuricemia
  • Serum urate
  • Treat-to-target
  • Care


Dive into the research topics of 'Quality of care in gout: a clinical audit on treating to the target with urate lowering therapy in real-world gout patients'. Together they form a unique fingerprint.

Cite this